Skip to content

Drug interactions

Sunitinib + Tipranavir

Severity: Major

Sunitinib and Tipranavir: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ritonavir-boosted tipranavir strongly inhibits CYP3A4 and may substantially raise sunitinib levels, increasing toxicity including QT prolongation. Tipranavir itself also induces enzymes in some pathways, making the net effect variable.

What this interaction means in plain words

Sunitinib and Tipranavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Sunitinib belongs to Oncology; Tipranavir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition by tipranavir/ritonavir reduces sunitinib clearance, with additive QT effects.

What to do

Use an alternative antiretroviral if possible. If combined, reduce the sunitinib dose and monitor ECG and for adverse effects.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sunitinib and Tipranavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Sunitinib with Tipranavir?

MediHelp rates the interaction as major. Sunitinib and Tipranavir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ritonavir-boosted tipranavir strongly inhibits CYP3A4 and may substantially raise sunitinib levels, increasing toxicity including QT prolongation. Tipranavir itself also induces enzymes in some pathways, making the net effect variable.

How serious is the interaction between Sunitinib and Tipranavir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use an alternative antiretroviral if possible. If combined, reduce the sunitinib dose and monitor ECG and for adverse effects.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in